The effects of the mediterranean diet on biomarkers of vascular wall inflammation and plaque vulnerability in subjects with high risk for cardiovascular disease. A randomized trial.

<h4>Background</h4>Adherence to the Mediterranean diet (MD) is associated with reduced morbidity and mortality due to cardiovascular disease. However, how the MD exerts its effects is not fully known.<h4>Aim</h4>To assess the 12-month effects of two enhanced MDs compared to a...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Rosa Casas, Emilio Sacanella, Mireia Urpí-Sardà, Gemma Chiva-Blanch, Emilio Ros, Miguel-Angel Martínez-González, Maria-Isabel Covas, Rosa Ma Lamuela-Raventos, Jordi Salas-Salvadó, Miquel Fiol, Fernando Arós, Ramon Estruch
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2014
Materias:
R
Q
Acceso en línea:https://doaj.org/article/cb0a0d89de9347e09dc7f40a554703b0
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:cb0a0d89de9347e09dc7f40a554703b0
record_format dspace
spelling oai:doaj.org-article:cb0a0d89de9347e09dc7f40a554703b02021-11-18T08:15:53ZThe effects of the mediterranean diet on biomarkers of vascular wall inflammation and plaque vulnerability in subjects with high risk for cardiovascular disease. A randomized trial.1932-620310.1371/journal.pone.0100084https://doaj.org/article/cb0a0d89de9347e09dc7f40a554703b02014-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24925270/pdf/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Background</h4>Adherence to the Mediterranean diet (MD) is associated with reduced morbidity and mortality due to cardiovascular disease. However, how the MD exerts its effects is not fully known.<h4>Aim</h4>To assess the 12-month effects of two enhanced MDs compared to a low-fat diet on inflammatory biomarkers related to atherosclerosis and plaque vulnerability in a subcohort of the PREDIMED (Prevención con Dieta Mediterránea) study.<h4>Methods</h4>A total of 164 participants at high risk for cardiovascular disease were randomized into three diet groups: MD supplemented with 50mL/d of extra virgin olive oil (MD+EVOO) or 30 g/d of nuts (MD+Nuts) and a low-fat diet. Changes in classical cardiovascular risk factors, inflammatory biomarkers of atherosclerosis and plaque vulnerability were measured after 12 months of intervention.<h4>Results</h4>Compared to participants in the low-fat diet group, those receiving MD+EVOO and MD+Nuts showed a higher decrease in systolic (6mmHg) and diastolic (3mmHg) blood pressure (P = 0.02; both), as well as a reduction of 10% and 8% in LDL-cholesterol (P = 0.04), respectively. Patients in the MD+Nuts group showed a significant reduction of 34% in CD40 expression on monocyte surface compared to low-fat diet patients (P = 0.03). In addition, inflammatory biomarkers related to plaque instability such as C-reactive protein and interleukin-6 were reduced by 45% and 35% and 95% and 90% in the MD+EVOO and MD+Nuts groups, respectively (P<0.05; all) compared to the low-fat diet group. Likewise, sICAM and P-selectin were also reduced by 50% and 27%, respectively in the MD+EVOO group (P = 0.04) and P-selectin by 19% in MD+Nuts group (P = 0.04) compared to the low-fat diet group.<h4>Conclusions</h4>Adherence to the MD is associated with an increase in serum markers of atheroma plaque stability which may explain, at least in part, the protective role of MD against ischemic heart disease.<h4>Trial registration</h4>www.controlled-trials.com ISRCTN35739639.Rosa CasasEmilio SacanellaMireia Urpí-SardàGemma Chiva-BlanchEmilio RosMiguel-Angel Martínez-GonzálezMaria-Isabel CovasRosa Ma Lamuela-RaventosJordi Salas-SalvadóMiquel FiolFernando ArósRamon EstruchPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 9, Iss 6, p e100084 (2014)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Rosa Casas
Emilio Sacanella
Mireia Urpí-Sardà
Gemma Chiva-Blanch
Emilio Ros
Miguel-Angel Martínez-González
Maria-Isabel Covas
Rosa Ma Lamuela-Raventos
Jordi Salas-Salvadó
Miquel Fiol
Fernando Arós
Ramon Estruch
The effects of the mediterranean diet on biomarkers of vascular wall inflammation and plaque vulnerability in subjects with high risk for cardiovascular disease. A randomized trial.
description <h4>Background</h4>Adherence to the Mediterranean diet (MD) is associated with reduced morbidity and mortality due to cardiovascular disease. However, how the MD exerts its effects is not fully known.<h4>Aim</h4>To assess the 12-month effects of two enhanced MDs compared to a low-fat diet on inflammatory biomarkers related to atherosclerosis and plaque vulnerability in a subcohort of the PREDIMED (Prevención con Dieta Mediterránea) study.<h4>Methods</h4>A total of 164 participants at high risk for cardiovascular disease were randomized into three diet groups: MD supplemented with 50mL/d of extra virgin olive oil (MD+EVOO) or 30 g/d of nuts (MD+Nuts) and a low-fat diet. Changes in classical cardiovascular risk factors, inflammatory biomarkers of atherosclerosis and plaque vulnerability were measured after 12 months of intervention.<h4>Results</h4>Compared to participants in the low-fat diet group, those receiving MD+EVOO and MD+Nuts showed a higher decrease in systolic (6mmHg) and diastolic (3mmHg) blood pressure (P = 0.02; both), as well as a reduction of 10% and 8% in LDL-cholesterol (P = 0.04), respectively. Patients in the MD+Nuts group showed a significant reduction of 34% in CD40 expression on monocyte surface compared to low-fat diet patients (P = 0.03). In addition, inflammatory biomarkers related to plaque instability such as C-reactive protein and interleukin-6 were reduced by 45% and 35% and 95% and 90% in the MD+EVOO and MD+Nuts groups, respectively (P<0.05; all) compared to the low-fat diet group. Likewise, sICAM and P-selectin were also reduced by 50% and 27%, respectively in the MD+EVOO group (P = 0.04) and P-selectin by 19% in MD+Nuts group (P = 0.04) compared to the low-fat diet group.<h4>Conclusions</h4>Adherence to the MD is associated with an increase in serum markers of atheroma plaque stability which may explain, at least in part, the protective role of MD against ischemic heart disease.<h4>Trial registration</h4>www.controlled-trials.com ISRCTN35739639.
format article
author Rosa Casas
Emilio Sacanella
Mireia Urpí-Sardà
Gemma Chiva-Blanch
Emilio Ros
Miguel-Angel Martínez-González
Maria-Isabel Covas
Rosa Ma Lamuela-Raventos
Jordi Salas-Salvadó
Miquel Fiol
Fernando Arós
Ramon Estruch
author_facet Rosa Casas
Emilio Sacanella
Mireia Urpí-Sardà
Gemma Chiva-Blanch
Emilio Ros
Miguel-Angel Martínez-González
Maria-Isabel Covas
Rosa Ma Lamuela-Raventos
Jordi Salas-Salvadó
Miquel Fiol
Fernando Arós
Ramon Estruch
author_sort Rosa Casas
title The effects of the mediterranean diet on biomarkers of vascular wall inflammation and plaque vulnerability in subjects with high risk for cardiovascular disease. A randomized trial.
title_short The effects of the mediterranean diet on biomarkers of vascular wall inflammation and plaque vulnerability in subjects with high risk for cardiovascular disease. A randomized trial.
title_full The effects of the mediterranean diet on biomarkers of vascular wall inflammation and plaque vulnerability in subjects with high risk for cardiovascular disease. A randomized trial.
title_fullStr The effects of the mediterranean diet on biomarkers of vascular wall inflammation and plaque vulnerability in subjects with high risk for cardiovascular disease. A randomized trial.
title_full_unstemmed The effects of the mediterranean diet on biomarkers of vascular wall inflammation and plaque vulnerability in subjects with high risk for cardiovascular disease. A randomized trial.
title_sort effects of the mediterranean diet on biomarkers of vascular wall inflammation and plaque vulnerability in subjects with high risk for cardiovascular disease. a randomized trial.
publisher Public Library of Science (PLoS)
publishDate 2014
url https://doaj.org/article/cb0a0d89de9347e09dc7f40a554703b0
work_keys_str_mv AT rosacasas theeffectsofthemediterraneandietonbiomarkersofvascularwallinflammationandplaquevulnerabilityinsubjectswithhighriskforcardiovasculardiseasearandomizedtrial
AT emiliosacanella theeffectsofthemediterraneandietonbiomarkersofvascularwallinflammationandplaquevulnerabilityinsubjectswithhighriskforcardiovasculardiseasearandomizedtrial
AT mireiaurpisarda theeffectsofthemediterraneandietonbiomarkersofvascularwallinflammationandplaquevulnerabilityinsubjectswithhighriskforcardiovasculardiseasearandomizedtrial
AT gemmachivablanch theeffectsofthemediterraneandietonbiomarkersofvascularwallinflammationandplaquevulnerabilityinsubjectswithhighriskforcardiovasculardiseasearandomizedtrial
AT emilioros theeffectsofthemediterraneandietonbiomarkersofvascularwallinflammationandplaquevulnerabilityinsubjectswithhighriskforcardiovasculardiseasearandomizedtrial
AT miguelangelmartinezgonzalez theeffectsofthemediterraneandietonbiomarkersofvascularwallinflammationandplaquevulnerabilityinsubjectswithhighriskforcardiovasculardiseasearandomizedtrial
AT mariaisabelcovas theeffectsofthemediterraneandietonbiomarkersofvascularwallinflammationandplaquevulnerabilityinsubjectswithhighriskforcardiovasculardiseasearandomizedtrial
AT rosamalamuelaraventos theeffectsofthemediterraneandietonbiomarkersofvascularwallinflammationandplaquevulnerabilityinsubjectswithhighriskforcardiovasculardiseasearandomizedtrial
AT jordisalassalvado theeffectsofthemediterraneandietonbiomarkersofvascularwallinflammationandplaquevulnerabilityinsubjectswithhighriskforcardiovasculardiseasearandomizedtrial
AT miquelfiol theeffectsofthemediterraneandietonbiomarkersofvascularwallinflammationandplaquevulnerabilityinsubjectswithhighriskforcardiovasculardiseasearandomizedtrial
AT fernandoaros theeffectsofthemediterraneandietonbiomarkersofvascularwallinflammationandplaquevulnerabilityinsubjectswithhighriskforcardiovasculardiseasearandomizedtrial
AT ramonestruch theeffectsofthemediterraneandietonbiomarkersofvascularwallinflammationandplaquevulnerabilityinsubjectswithhighriskforcardiovasculardiseasearandomizedtrial
AT rosacasas effectsofthemediterraneandietonbiomarkersofvascularwallinflammationandplaquevulnerabilityinsubjectswithhighriskforcardiovasculardiseasearandomizedtrial
AT emiliosacanella effectsofthemediterraneandietonbiomarkersofvascularwallinflammationandplaquevulnerabilityinsubjectswithhighriskforcardiovasculardiseasearandomizedtrial
AT mireiaurpisarda effectsofthemediterraneandietonbiomarkersofvascularwallinflammationandplaquevulnerabilityinsubjectswithhighriskforcardiovasculardiseasearandomizedtrial
AT gemmachivablanch effectsofthemediterraneandietonbiomarkersofvascularwallinflammationandplaquevulnerabilityinsubjectswithhighriskforcardiovasculardiseasearandomizedtrial
AT emilioros effectsofthemediterraneandietonbiomarkersofvascularwallinflammationandplaquevulnerabilityinsubjectswithhighriskforcardiovasculardiseasearandomizedtrial
AT miguelangelmartinezgonzalez effectsofthemediterraneandietonbiomarkersofvascularwallinflammationandplaquevulnerabilityinsubjectswithhighriskforcardiovasculardiseasearandomizedtrial
AT mariaisabelcovas effectsofthemediterraneandietonbiomarkersofvascularwallinflammationandplaquevulnerabilityinsubjectswithhighriskforcardiovasculardiseasearandomizedtrial
AT rosamalamuelaraventos effectsofthemediterraneandietonbiomarkersofvascularwallinflammationandplaquevulnerabilityinsubjectswithhighriskforcardiovasculardiseasearandomizedtrial
AT jordisalassalvado effectsofthemediterraneandietonbiomarkersofvascularwallinflammationandplaquevulnerabilityinsubjectswithhighriskforcardiovasculardiseasearandomizedtrial
AT miquelfiol effectsofthemediterraneandietonbiomarkersofvascularwallinflammationandplaquevulnerabilityinsubjectswithhighriskforcardiovasculardiseasearandomizedtrial
AT fernandoaros effectsofthemediterraneandietonbiomarkersofvascularwallinflammationandplaquevulnerabilityinsubjectswithhighriskforcardiovasculardiseasearandomizedtrial
AT ramonestruch effectsofthemediterraneandietonbiomarkersofvascularwallinflammationandplaquevulnerabilityinsubjectswithhighriskforcardiovasculardiseasearandomizedtrial
_version_ 1718422012160901120